Actively Recruiting
HUMSCs Combined With Col I to Third-Degree Burn Wound
Led by The First Affiliated Hospital of Xinxiang Medical College · Updated on 2026-05-04
108
Participants Needed
1
Research Sites
142 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells combined with bovine type I collagen in the treatment of third-degree burn wounds.
CONDITIONS
Official Title
HUMSCs Combined With Col I to Third-Degree Burn Wound
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18-65 years, gender unrestricted
- Confirmed third-degree burns with wound area 1%-5% total body surface area
- Admission within 72 hours after burn injury
- Voluntarily signed informed consent
- Able to cooperate and complete follow-up
You will not qualify if you...
- Pregnant or lactating females
- Severe immunodeficiency or autoimmune disease
- History of malignant tumor or coagulation dysfunction
- Severe cardiac, hepatic, or renal insufficiency
- Hypersensitivity to collagen or stem cell components
- Uncontrollable severe wound infection
- Participation in other clinical studies within the past 3 months
- Inability to comply with follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Xinxiang Medical College
Xinxiang, Henan, China
Actively Recruiting
Research Team
W
Wenjie Ren
CONTACT
W
Wenjie Ren
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here